CureVac NV (CVAC)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$1.05B
EV to revenue ratio (TTM)
7.23
EV to ebitda
2.82
Financial Performance
Revenue (TTM)
$0.07B
Gross profit (TTM)
$0.07B
EBITDA
$0.19B
Profitability
Operating margin (TTM)
573.00%
Profit margin
182.10%
Return on assets (TTM)
23.80%
Return on equity (TTM)
40.20%
Per Share Metrics
Revenue per share (TTM)
$0.44
EPS
$0.67
Diluted EPS (TTM)
$0.67
Book value
$5.63
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
6.96
Trailing P/E
6.96
Forward P/E
5.24
PEG ratio
n/a
Price to sales ratio (TTM)
14.83
Price to book ratio (TTM)
1.03
Growth
Quarterly earnings growth (YoY)
-89.00%
Quarterly revenue growth (YoY)
24.00%
Analyst Sentiment
Strong buy
n/a
Buy
n/a
Hold
n/a
Sell
n/a
Strong sell
n/a
Risk & Volatility
Beta
1.84